Ravdin PM - Search Results

1

Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinoma.

Trump DL, Ravdin PM, Borden EC, Magers CF, Whisnant JK. Trump DL, et al. Among authors: ravdin pm. J Biol Response Mod. 1990 Feb;9(1):108-11. J Biol Response Mod. 1990. PMID: 2319258

2

A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies.

Petit T, Aylesworth C, Burris H, Ravdin P, Rodriguez G, Smith L, Peacock N, Smetzer L, Bellet R, Von Hoff DD, Rowinsky EK. Petit T, et al. Ann Oncol. 1999 Feb;10(2):223-9. doi: 10.1023/a:1008356025108. Ann Oncol. 1999. PMID: 10093693 Free article. Clinical Trial.

3

Docetaxel in combination with fluorouracil: study design and preliminary results.

Rowinsky E, Smith L, Rodriguez G, White L, Drengler R, Von Hoff D, Peacock N, Aylesworth C, Burris H, Ravdin P, Bellet R. Rowinsky E, et al. Oncology (Williston Park). 1997 Jun;11(6 Suppl 6):33-5. Oncology (Williston Park). 1997. PMID: 9213326 Clinical Trial.

4

The international experience with docetaxel in the treatment of breast cancer.

Ravdin PM. Ravdin PM. Oncology (Williston Park). 1997 Mar;11(3 Suppl 2):38-42. Oncology (Williston Park). 1997. PMID: 9110341 Free article. Review.

5

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

Ravdin PM, Burris HA 3rd, Cook G, Eisenberg P, Kane M, Bierman WA, Mortimer J, Genevois E, Bellet RE. Ravdin PM, et al. J Clin Oncol. 1995 Dec;13(12):2879-85. doi: 10.1200/JCO.1995.13.12.2879. J Clin Oncol. 1995. PMID: 8523050 Clinical Trial.

6

Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.

Ravdin PM, Fritz NF, Tormey DC, Jordan VC. Ravdin PM, et al. Cancer Res. 1988 Feb 15;48(4):1026-9. Cancer Res. 1988. PMID: 3123050

7

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

Valero V, Jones SE, Von Hoff DD, Booser DJ, Mennel RG, Ravdin PM, Holmes FA, Rahman Z, Schottstaedt MW, Erban JK, Esparza-Guerra L, Earhart RH, Hortobagyi GN, Burris HA 3rd. Valero V, et al. Among authors: ravdin pm. J Clin Oncol. 1998 Oct;16(10):3362-8. doi: 10.1200/JCO.1998.16.10.3362. J Clin Oncol. 1998. PMID: 9779713 Clinical Trial.

8

Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.

Ravdin PM. Ravdin PM. Semin Oncol. 1999 Jun;26(3 Suppl 9):20-3. Semin Oncol. 1999. PMID: 10426455 Review.

9

Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer.

Osborne CK, Sunderland MC, Neidhart JA, Ravdin PM, Abeloff MD. Osborne CK, et al. Among authors: ravdin pm. Ann Oncol. 1994 Jan;5(1):43-7. doi: 10.1093/oxfordjournals.annonc.a058689. Ann Oncol. 1994. PMID: 8172792 Free article. Clinical Trial.

10

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ, et al. Ravdin PM, et al. J Clin Oncol. 1992 Aug;10(8):1284-91. doi: 10.1200/JCO.1992.10.8.1284. J Clin Oncol. 1992. PMID: 1634918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters